All Posts
Clinical trial finds vitamin D does not ward off colds and flu
15 Jan, 2021 | 08:33h | UTC
Study: Pulmonary embolism detected in 6% of patients with COPD admitted to the hospital with acute worsening of respiratory symptoms
15 Jan, 2021 | 08:37h | UTCPrevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory Symptoms – JAMA (link to abstract – $ for full-text)
Study: Seizure frequency does not increase during Pregnancy
15 Jan, 2021 | 08:28h | UTCChanges in Seizure Frequency and Antiepileptic Therapy during Pregnancy – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: MONEAD Study: Does Pregnancy Lead to Increased Seizure Frequency in Women with Epilepsy? – Physician’s Weekly AND Pregnancy Does Not Increase Seizures in Women With Epilepsy – Medscape
Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019)
15 Jan, 2021 | 08:26h | UTC
Commentary on Twitter
Great paper with lots of interesting data. What strikes me most: the drawbacks (retaliation) the clinicians experienced who reported the severe adverse drug reactions (several were sued by Big Pharma, one lost his professorship)https://t.co/NimX0rnsAt
— Michael P. Hengartner, PhD (@HengartnerMP) December 26, 2020
Cohort study: Piperacillin/tazobactam linked to increased risk of acute kidney injury when compared to cefepime or meropenem
15 Jan, 2021 | 08:24h | UTC
Commentary on Twitter
NEW 🔥🔥 #CID @IDSAInfo
Risk of AKI & CDI with piperacillin/tazobactam, cefepime and meropenem with or without vancomycin #IDTwitter @danlivorsi
TZP ⬆️ AKI risk, which was exacerbated by concurrent vancomycin.
FEP&MER ⬆️CDI risk relative to TZP. https://t.co/0pIurl7A7w pic.twitter.com/ZjjvN2rkWP— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) December 31, 2020
Randomized trial: Biological mesh results in significantly more complications compared to synthetic mesh in noncomplex ventral hernia repair
15 Jan, 2021 | 08:17h | UTCSynthetic Versus Biological Mesh in Laparoscopic and Open Ventral Hernia Repair (LAPSIS): Results of a Multinational, Randomized, Controlled, and Double-blind Trial – Annals of Surgery (link to abstract – $ for full-text)
Commentary on Twitter
The use of biological mesh resulted in significantly more complications (P = 0.013),also after adjusting for hernia type, body mass index,and study site.The trial was prematurely stopped due to unacceptable high recurrence rate in the biological mesh arms https://t.co/P0fV50xopv
— George Ferzli (@drferzli) December 25, 2020
Randomized trial: Surgical and drug treatment options lead to similar outcomes for diabetic eye disease
15 Jan, 2021 | 08:22h | UTCOriginal Study: Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)
Commentary on Twitter
In this RCT, intravitreous aflibercept vs vitrectomy + panretinal photocoagulation did not improve visual acuity over 24 weeks in patients with vitreous hemorrhage from proliferative diabetic retinopathy; the study may have been underpowered https://t.co/n4px6kFF5Z
— JAMA (@JAMA_current) December 18, 2020
[Abstract Only] A randomized clinical trial of low dose warfarin therapy for improving the longevity of permanent arteriovenous catheters
15 Jan, 2021 | 08:18h | UTCA randomized clinical trial of low dose warfarin therapy for improving the longevity of permanent arteriovenous catheters – Annals of Vascular Surgery (link to abstract – $ for full-text)
CSCO and ASCO Guideline: Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma
15 Jan, 2021 | 08:14h | UTC
Randomized trial: Cannula with long and narrow tubing noninferior to short binasal prongs for noninvasive ventilation in preterm infants
15 Jan, 2021 | 08:15h | UTCCannula With Long and Narrow Tubing vs Short Binasal Prongs for Noninvasive Ventilation in Preterm Infants: Noninferiority Randomized Clinical Trial – JAMA Pediatrics (link to abstract – $ for full-text)
Commentary: Israeli study finds effective, less invasive way to treat preterm babies – The Jerusalem Post
Commentary on Twitter
New RCT on @JAMAPediatrics shows cannulas with long and narrow tubing (CLNT) to be noninferior to short binasal prongs and masks (SPM) in providing NIPPV for preterm infants, while causing significantly less nasal trauma: https://t.co/zdW6zcM7NY #neoEBM #ebneoalerts pic.twitter.com/Q9qBQLxdwT
— Evidence-Based Neo (@EBNEO) November 15, 2020
Randomized trial: Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma
15 Jan, 2021 | 08:12h | UTCOnce-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial – The Lancet (link to abstract – $ for full-text)
Commentary: Triplet therapy slows refractory multiple myeloma – MedicalXpress
Systematic review: Prostatic arterial embolization for men with symptomatic benign prostatic hyperplasia provides similar short term (up to 12 months) improvement in urologic symptom scores and quality of life, but with an increase in re-treatment rates
15 Jan, 2021 | 08:11h | UTC
Systematic review: Adding abiraterone acetate to androgen deprivation therapy for the treatment of metastatic hormone-sensitive prostate cancer
15 Jan, 2021 | 08:10h | UTC
CoronaVac study in Brazil: Is the vaccine 50%, 78%, or 100% effective?
14 Jan, 2021 | 02:11h | UTCThird time’s the charm? Brazil scales back efficacy claims for COVID-19 vaccine from China – Science
See also: CoronaVac’s Overall Efficacy in Brazil Measured at 50.4% – Bloomberg
Systematic review: Oral hygiene care with chlorhexidine mouthwash or gel in critically ill patients probably reduces the incidence of developing ventilator-associated pneumonia
15 Jan, 2021 | 08:09h | UTC
Meta-analysis: Saliva vs. nasopharyngeal swabs equally sensitive for Covid-19 diagnosis
14 Jan, 2021 | 02:13h | UTCCommentary: Saliva, Nasopharyngeal Samples Equally Sensitive for SARS-CoV-2 – Physician’s Weekly
Commentary on Twitter
https://twitter.com/EricTopol/status/1348758183846703104
A guide to vaccinology: from basic principles to new developments
14 Jan, 2021 | 02:09h | UTCA guide to vaccinology: from basic principles to new developments – Nature Reviews Immunology
Pragmatic Recommendations for the Management of COVID-19 in Low- and Middle-Income Countries
14 Jan, 2021 | 02:04h | UTC- Editorial: Recommendations for the Management of COVID-19 in Low- and Middle-Income Countries – The American Journal of Tropical Medicine and Hygiene
- Pragmatic Recommendations for the Management of Acute Respiratory Failure and Mechanical Ventilation in Patients with COVID-19 in Low- and Middle-Income Countries – The American Journal of Tropical Medicine and Hygiene
- Pragmatic Recommendations for the Management of Anticoagulation and Venous Thrombotic Disease for Hospitalized Patients with COVID-19 in Low- and Middle-Income Countries – The American Journal of Tropical Medicine and Hygiene
- Pragmatic Recommendations for Identification and Triage of Patients with COVID-19 Disease in Low- and Middle-Income Countries – The American Journal of Tropical Medicine and Hygiene
- Pragmatic Recommendations for Tracheostomy, Discharge, and Rehabilitation Measures in Hospitalized Patients Recovering From Severe COVID-19 in Low- and Middle-Income Countries – The American Journal of Tropical Medicine and Hygiene
- Pragmatic Recommendations for the Prevention and Treatment of Acute Kidney Injury in Patients with COVID-19 in Low- and Middle-Income Countries – The American Journal of Tropical Medicine and Hygiene
- Pragmatic Recommendations for Infection Prevention and Control Practices for Healthcare Facilities in Low- and Middle-Income Countries during the COVID-19 Pandemic – Journal of Tropical Medicine and Hygiene
How COVID unlocked the power of RNA vaccines
14 Jan, 2021 | 02:09h | UTCHow COVID unlocked the power of RNA vaccines – Nature
Commentary: RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics? – Frontiers in Immunology
Three studies highlight low COVID risk of in-person school
14 Jan, 2021 | 02:06h | UTCThree studies highlight low COVID risk of in-person school – CIDRAP
Study 1: Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden – New England Journal of Medicine
Study 2: Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools – Pediatrics
No ICU beds? Expect double the number of Covid-19 deaths
14 Jan, 2021 | 02:05h | UTCNo ICU beds? Expect double the number of Covid-19 deaths. – Vox
Study estimates 50% of new SARS-CoV-2 infections have originated from exposure to asymptomatic or pre-symptomatic individuals
14 Jan, 2021 | 02:08h | UTCSARS-CoV-2 Transmission From People Without COVID-19 Symptoms – JAMA Network Open
Commentary: At least 50% of COVID-19 cases spread from people without symptoms, a new study found – Business Insider AND More than half of Covid-19 infections acquired from asymptomatic carriers – MedicalResearch
Commentary on Twitter
https://twitter.com/TennantRuth/status/1348208811039985665
Perspective: For people with OCD — and fearful of germs — the pandemic is upending years of therapy
14 Jan, 2021 | 02:00h | UTCFor people with OCD — and fearful of germs — the pandemic is upending years of therapy – STAT
Preparing previously COVID-19-positive patients for elective surgery: A framework for preoperative evaluation
14 Jan, 2021 | 02:02h | UTC
Study: Despite recommendations, less than 2 percent of patients with treatment-resistant hypertension were tested for primary aldosteronism in a large U.S. cohort
14 Jan, 2021 | 01:55h | UTCTesting for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans: A Retrospective Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries: Primary Aldosteronism Testing Rare in Treatment-Resistant HTN – HealthDay AND Primary Aldosteronism Testing Rare for Patients with Resistant Hypertension – NEJM Journal Watch
Commentary from the author on Twitter (thread – click for more)
Our new study is out in @AnnalsofIM w/@BhallaResearch @thebyrdlab @johnleppert! 👇https://t.co/UCrAD4ed0w
We asked: Are patients w/treatment resistant HTN being appropriately tested for primary aldosteronism (PA) & managed w/mineralocorticoid receptor antagonists (MRAs)? 1/ pic.twitter.com/jO4cqA37sD
— Jordy Cohen, MD, MSCE (@jordy_bc) December 28, 2020


